Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123151212 | 12315121 | 2 | F | 201603 | 20160629 | 20160428 | 20160707 | PER | US-ASTRAZENECA-2016SE42991 | ASTRAZENECA | 895.00 | MON | F | Y | 73.00000 | KG | 20160707 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123151212 | 12315121 | 1 | PS | ANASTROZOLE. | ANASTROZOLE | 1 | Oral | U | 20541 | TABLET | |||||||||
| 123151212 | 12315121 | 2 | SS | AROMASIN | EXEMESTANE | 1 | Unknown | Y | 0 | 45 | MG | TABLET | QD | ||||||
| 123151212 | 12315121 | 3 | SS | LETROZOLE. | LETROZOLE | 1 | Unknown | U | 0 | ||||||||||
| 123151212 | 12315121 | 4 | C | EDARBI | AZILSARTAN KAMEDOXOMIL | 1 | 0 | 40 | MG | QD | |||||||||
| 123151212 | 12315121 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123151212 | 12315121 | 4 | Blood pressure abnormal |
| 123151212 | 12315121 | 5 | Blood pressure abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123151212 | 12315121 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123151212 | 12315121 | Alopecia | |
| 123151212 | 12315121 | Arthritis | |
| 123151212 | 12315121 | Back disorder | |
| 123151212 | 12315121 | Confusional state | |
| 123151212 | 12315121 | Depressed mood | |
| 123151212 | 12315121 | Disease recurrence | |
| 123151212 | 12315121 | Gait disturbance | |
| 123151212 | 12315121 | Joint swelling | |
| 123151212 | 12315121 | Malaise | |
| 123151212 | 12315121 | Memory impairment | |
| 123151212 | 12315121 | Morbid thoughts | |
| 123151212 | 12315121 | Peripheral swelling | |
| 123151212 | 12315121 | Visual acuity reduced | |
| 123151212 | 12315121 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123151212 | 12315121 | 2 | 20160301 | 201603 | 0 |